Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

70.16
Delayed Data
As of 4:00pm ET
 +0.76 / +1.10%
Today’s Change
11.41
Today|||52-Week Range
75.33
+17.48%
Year-to-Date

Today’s Trading

Previous close69.40
Today’s open69.25
Day’s range68.15 - 70.91
Volume1,552,996
Average volume (3 months)2,144,873
Market cap$10.9B
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+31.82%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book120.66

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc+5.30+5.05%
ONCESpark Therapeutics I...-0.98-1.90%
XONIntrexon Corp-0.62-4.35%
JUNOJuno Therapeutics In...+2.12+3.06%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts